,outcome,arm 1,arm 2
0,intervention,"amantadine, amantadine-treated group",placebo
0,,amantadine,NR
0,absolute changes in clinician-rated ABC-CVs for hyperactivity,"-1.9, -2.1 ; p = .046 ), -6.4","-2.1 ; p = .046 ), 0.4"
